期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

ⅢA-N2期非小细胞肺癌以手术为主的综合治疗的现状及前景 被引量：1

下载PDF
导出
摘要 目前,肺癌已经严重威胁到人类的健康,据统计,肺癌在癌症死亡原因中占据首位[1]。2014年我国肿瘤登记中心发布的数据显示,2010年我国新发肺癌病例60.59万,居恶性肿瘤首位,占恶性肿瘤新发病例的19.59%;同期我国肺癌死亡人数为48.66万,占恶性肿瘤死因的24.87%;非小细胞肺癌(non-small cell lung cancer,NSCLC)约占全部肺癌的80%,其中20%为ⅢA-N2期[2-3]。
作者 李其才 王祖义
机构地区 蚌埠医学院第一附属医院胸外科
出处 《包头医学院学报》 CAS 2018年第4期126-129,共4页 Journal of Baotou Medical College
关键词 非小细胞肺癌 N2期 以手术为主 综合治疗 恶性肿瘤 新发病例 NSCLC 死亡原因
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献2

二级参考文献16

  • 1DOUILLARD J, ROSELL R, DELENA M,et al. ANITA:Phase M adjuvant vinorelbine (N) and cisplatin (P) versusobservation (OBS) in completely resected (stage I -HI) non-small-cell lung cancer (NSCLC) patients (pts): Final resultsafter 70-month median follow-up. On behalf of the AdjuvantNavelbine International Trialist Association [ J ] . J ClinOncol, 2005, 23(3): 624.
  • 2DAI H, HUI Z, JI W, et al. Postoperative radiotherapy forresected pathological stage Ma-N2 non-small cell lungcancer: a retrospective study of 221 cases from a singleinstitution [ J ] . Oncologist, 2011, 16(5): 641-650.
  • 3MORETTI L,YU D S,CHEN H, et al. Prognostic factorsfor resected non-small cell lung cancer with pN2 status:implications for use of postoperative radiotherapy [ J ].Oncologist, 2009, 14: 1106-1115.
  • 4WALSH G L, O'CONNER M, WILLIS K M, et al. Is follow-upof lung cancer patient after resection medically indicated andcost-effective [ J ] . Ann Thorac Surg, 1995,60(4): 1563-1572.
  • 5KARAKOYUN-CELIK 0,YALMAN D, BOLUKBASI Y, etal. Postoperative radiotherapy in the management of resectednon-small-cell lung carcinoma: 10 years’ experience ina single institute [ J ] . Int J Radiat Oncol Biol Phys, 2010,76(2): 433-439.
  • 6LE PECHOUX C. Role of postoperative radiotherapy inresected non—small cell lung cancer: a reassessment based onnew data [ J ] . The Oncologist, 2011,16(5): 672-681.
  • 7DOUILLARD J Y, ROSELL R, DE LENA M,et al. Impact ofpostoperative radiation therapy on survival in patients withcomplete resection and stage I , II, or HI A non-small-cell lung cancer treated with adjuvant chemotherapy: theAdjuvant Navelbine International Trialist Association (ANITA)Randomized Trial [ J ] . Radiat Oncol Biol Phys, 2008, 72(3):695-701.
  • 8DECALUWE H,De LEYN P, VANSTEENKISTE J, et al.Surgical multimodaiity treatment for baseline resectable stageHI A-N2 non-small cell lung cancer. Degree of mediastinallymph node involvement and impact on survival [ J ] . Eur JCardiothorac Surg, 2009, 36(3): 433-439.
  • 9VANSTEENKISTE J F,DE LEYN P R, DENEFFE G J, et al.Clinical prognostic factors in surgically treated stage IH A-N2non—small cell lung cancer: analysis of the literature [ J ].Lung Cancer, 1998,19(1): 3-13.
  • 10ZHAO L J,JI W, OU G, et al. Risk factors for radiation-induced lung toxicity in patients with non-small cell lungcancer who received postoperative radiation therapy [ J ].Lung Cancer,2012,77(2): 326-330.

共引文献204

同被引文献2

引证文献1

二级引证文献1

包头医学院学报
2018年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部